Beghi E (2016) Addressing the burden of epilepsy: many unmet needs. Pharmacol Res 107:79–84. https://doi.org/10.1016/j.phrs.2016.03.003

Article  PubMed  Google Scholar 

Carcak N, Ozkara C (2017) Seizures and antiepileptic drugs: from pathophysiology to clinical practice. Curr Pharm des 23:6376–6388. https://doi.org/10.2174/1381612823666171115101557

Article  PubMed  Google Scholar 

Ceylan M, Bayraktutan O, Yaln A (2015) Neutropenia associated with topiramate monotherapy: adverse effects associated with topiramate usage. J Neurol Res 5:264–266. https://doi.org/10.14740/jnr353w

Chen XY, Liu GG, Wang CM, Liu R, Wang MH, Huang YZ, Shen J, Jia YW (2023) Quantification of cefaclor in human plasma using SIL-IS LC-ESI-MS/MS for pharmacokinetics study in healthy Chinese volunteers. Biomed Chromatogr 37:e5638. https://doi.org/10.1002/bmc.5638

Article  PubMed  Google Scholar 

Chen XY, Chen T, Huang YZ, Wang MH, Wang YQ, Wu P, Xia XC, Du PF, Wu JB, Shen J, Jia YW (2024) LC-MS/MS method for quick detection of vonoprazan fumarate in human plasma: development, validation and its application to a bioequivalence study. Biomed Chromatogr 38:e5860. https://doi.org/10.1002/bmc.5860

Article  PubMed  Google Scholar 

Cosentino G, Conrad AO, Uwaifo GI (2013) Phentermine and topiramate for the management of obesity: a review. Drug Des Devel Ther 7:267–278. https://doi.org/10.2147/dddt.S31443

Article  PubMed  Google Scholar 

Doose DR, Walker SA, Gisclon LG, Nayak RK (1996) Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug. J Clin Pharmacol 36:884–891. https://doi.org/10.1002/j.1552-4604.1996.tb04754.x

Article  PubMed  Google Scholar 

EMA (2011) Guideline on bioanalytical method validation (EB/OL). https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf. Accessed 20 Nov 2023

Faught E (2007) Topiramate in the treatment of partial and generalized epilepsy. Neuropsychiatr Dis Treat 3:811–821. https://doi.org/10.2147/ndt.s512

Article  PubMed  PubMed Central  Google Scholar 

FDA (2010) Clinical review of topiramate. Available from: https://www.fda.gov/media/81504/download. Accessed 20 Nov 2023

FDA (2014) Topiramate prescribing information. Available from: https://www.fda.gov/advisory-committees/pediatric-advisory-committee/topamax-topiramate-briefing-materials. Accessed 20 Nov 2023

FDA (2018) Guidance for industry: bioanalytical method validation (EB/OL). https://www.fda.gov/media/70858/download. Accessed 20 Nov 2023

Gisclon LG, Riffitts JM, Sica DA et al (1993) The pharmacokinetics (PK) of topiramate (T) in subjects with renal impairment (RI) as compared to matched subjects with normal renal function (NRF). Pharm Res 10(suppl):S397

Google Scholar 

Guerrini R, Parmeggiani L (2006) Topiramate and its clinical applications in epilepsy. Expert Opin Pharmacother 7:811–823. https://doi.org/10.1517/14656566.7.6.811

Article  PubMed  Google Scholar 

Hansen CC, Ljung H, Brodtkorb E, Reimers A (2018) Mechanisms underlying aggressive behavior induced by antiepileptic drugs: focus on topiramate, levetiracetam, and perampanel. Behav Neurol 2018:2064027. https://doi.org/10.1155/2018/2064027

Article  PubMed  PubMed Central  Google Scholar 

He XJ, Liu GG, Chen XY, Wang YQ, Liu R, Wang CM, Huang YZ, Shen J, Jia YW (2023) Pharmacokinetic and pharmacodynamic interactions between henagliflozin, a novel selective SGLT-2 inhibitor, and warfarin in healthy Chinese subjects. Clin Ther 45:655–661. https://doi.org/10.1016/j.clinthera.2023.06.002

Article  PubMed  Google Scholar 

Huang YZ, Jia YW, Chen XY, Wang CM, Wang YQ, Wang MH, Wu P, Shen J (2023) CYP3A inhibitor itraconazole affect pharmacokinetic behavior of famitinib and its active metabolite: results of a single-center, single-arm, open-label and fixed sequence study. Expert Opin Drug Metab Toxicol 19:1005–1013. https://doi.org/10.1080/17425255.2023.2292112

Article  PubMed  Google Scholar 

Janmohamed M, Brodie MJ, Kwan P (2020) Pharmacoresistance - epidemiology, mechanisms, and impact on epilepsy treatment. Neuropharmacology 168:107790. https://doi.org/10.1016/j.neuropharm.2019.107790

Article  PubMed  Google Scholar 

Khalil NY, AlRabiah HK, Al Rashoud SS, Bari A, Wani TA (2019) Topiramate: comprehensive profile. Profiles Drug Subst Excip Relat Methodol 44:333–378. https://doi.org/10.1016/bs.podrm.2018.11.005

Article  PubMed  Google Scholar 

Löscher W, Potschka H, Sisodiya SM, Vezzani A (2020) Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev 72:606–638. https://doi.org/10.1124/pr.120.019539

Article  PubMed  PubMed Central  Google Scholar 

Lyseng-Williamson KA, Yang LP (2008) Spotlight on topiramate in epilepsy. CNS Drugs 22:171–174. https://doi.org/10.2165/00023210-200822020-00007

Article  PubMed  Google Scholar 

Minton GC, Miller AD, Bookstaver PB, Love BL (2011) Topiramate: safety and efficacy of its use in the prevention and treatment of migraine. J Cent Nerv Syst Dis 3:155–168. https://doi.org/10.4137/jcnsd.S4365

Article  PubMed  PubMed Central  Google Scholar 

NMPA (2005) Technical guidelines for the study of bioavailability and bioequivalence of chemical drug products in humans. Available from: https://www.nmpa.gov.cn/wwwroot/gsz05106/08.pdf. Accessed 20 Nov 2023

NMPA (2020) 9012 guidelines for validation of quantitative analysis methods for biological samples (EB/OL). https://www.nmpa.gov.cn/. Accessed 20 Nov 2023

Nortey SO, Wu WN, Maryanoff BE (1997) Synthesis of hydroxylated derivatives of topiramate, a novel antiepileptic drug based on D-fructose: investigation of oxidative metabolites. Carbohydr Res 304:29–38. https://doi.org/10.1016/s0008-6215(97)00214-0

Article  PubMed  Google Scholar 

Park JH, Park YS, Lee MH, Rhim SY, Song JC, Lee SJ, Kim JM, Shaw LM, Kang JS (2008) Determination of plasma topiramate concentration using LC-MS/MS for pharmacokinetic and bioequivalence studies in healthy Korean volunteers. Biomed Chromatogr 22:822–829. https://doi.org/10.1002/bmc.995

Article  PubMed  Google Scholar 

Pearl NZ, Babin CP, Catalano NT, Blake JC, Ahmadzadeh S, Shekoohi S, Kaye AD (2023) Narrative review of topiramate: clinical uses and pharmacological considerations. Adv Ther 40:3626–3638. https://doi.org/10.1007/s12325-023-02586-y

Article  PubMed  Google Scholar 

Perucca E (1997) A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res 35:241–256. https://doi.org/10.1006/phrs.1997.0124

Article  PubMed  Google Scholar 

Piñeyro-López A, Piñeyro-Garza E, Gómez-Silva M, Reyes-Araiza R, Flores-Diego MA, Borrego-Alvarado S, Gamino-Peña ME, Vargas-Zapata R, Salazar-Leal ME (2009) Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers. Clin Ther 31:411–417. https://doi.org/10.1016/j.clinthera.2009.02.001

Article  PubMed  Google Scholar 

Qiu BF, Liu GG, Wang CM, Chen XY, Liu R, Huang YZ, Jia YW, Shen J (2023) Three-period bioequivalence study of sodium levofolinate injection with calcium levofolinate for injection and sodium folinate for injection in healthy Chinese subjects. Clin Pharmacol Drug Dev 12:416–423. https://doi.org/10.1002/cpdd.1223

Article  PubMed  Google Scholar 

Rosenfeld WE (1997) Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther 19:1294–1308. https://doi.org/10.1016/s0149-2918(97)80006-9

Article  PubMed  Google Scholar 

Wang CM, Wang YQ, Xie HT, Zhan CJ, He XJ, Liu R, Hu RF, Shen J, Jia YW (2022) Establishment and validation of an SIL-IS LC-MS/MS method for the determination of ibuprofen in human plasma and its pharmacokinetic study. Biomed Chromatogr 36:e5287. https://doi.org/10.1002/bmc.5287

Article  PubMed  Google Scholar 

Zhan CJ, Wang CM, Wang YQ, Xie HT, Chu JR, Zhang R, Hu RF, Shen J, Jia YW (2021) Using a stable isotope-labeled internal standard for liquid chromatography-tandem mass spectrometry quantitation of meloxicam in human plasma. Biomed Chromatogr 35:e5217. https://doi.org/10.1002/bmc.5217

Article  PubMed  Google Scholar